BSE announces listing of 21,12,994 new equity shares of Trident Texofab Limited from July 28, 2025, issued through warrant conversion on preferential basis.
Impact
Low
Severity
Low
Justification
Routine listing of new shares through warrant conversion with minimal market impact due to small number of shares relative to total equity base